Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2003-4-25
pubmed:abstractText
The objectives of this study were to characterize the differential potency of two major VEGF isoforms, VEGF(120) and VEGF(164), for inducing leukocyte stasis (leukostasis) within the retinal vasculature and blood-retinal barrier (BRB) breakdown and to determine whether endogenous VEGF(164) mediates retinal leukostasis and BRB breakdown in early and established diabetes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD45, http://linkedlifedata.com/resource/pubmed/chemical/Concanavalin A, http://linkedlifedata.com/resource/pubmed/chemical/Endothelial Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/Fluorescein-5-isothiocyanate, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Adhesion Molecule-1, http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides..., http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines, http://linkedlifedata.com/resource/pubmed/chemical/NX1838, http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides, http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/fluorescein...
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0146-0404
pubmed:author
pubmed:issnType
Print
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2155-62
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:12714656-Animals, pubmed-meshheading:12714656-Antigens, CD45, pubmed-meshheading:12714656-Blood-Retinal Barrier, pubmed-meshheading:12714656-Blotting, Western, pubmed-meshheading:12714656-Capillary Permeability, pubmed-meshheading:12714656-Concanavalin A, pubmed-meshheading:12714656-Diabetes Mellitus, Experimental, pubmed-meshheading:12714656-Diabetic Retinopathy, pubmed-meshheading:12714656-Endothelial Growth Factors, pubmed-meshheading:12714656-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:12714656-Fluorescein-5-isothiocyanate, pubmed-meshheading:12714656-Immunohistochemistry, pubmed-meshheading:12714656-Injections, pubmed-meshheading:12714656-Intercellular Adhesion Molecule-1, pubmed-meshheading:12714656-Intercellular Signaling Peptides and Proteins, pubmed-meshheading:12714656-Leukostasis, pubmed-meshheading:12714656-Lymphokines, pubmed-meshheading:12714656-Oligonucleotides, pubmed-meshheading:12714656-Protein Isoforms, pubmed-meshheading:12714656-Rats, pubmed-meshheading:12714656-Rats, Long-Evans, pubmed-meshheading:12714656-Retinal Vessels, pubmed-meshheading:12714656-Vascular Endothelial Growth Factor A, pubmed-meshheading:12714656-Vascular Endothelial Growth Factors, pubmed-meshheading:12714656-Vitreous Body
pubmed:year
2003
pubmed:articleTitle
VEGF164 is proinflammatory in the diabetic retina.
pubmed:affiliation
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
pubmed:publicationType
Journal Article, Comparative Study